BDBM204875 EA8/MRS5817::US9227979, 24

SMILES Cn1cc2c(n1)nc(NC(=O)Nc1ccc(CC(=O)NCCCCCNC(=S)Nc3ccc(c(c3)C([O-])=O)-c3c4ccc(O)cc4oc4cc(=O)ccc34)cc1)n1nc(nc21)-c1ccco1

InChI Key InChIKey=RXXLYTXIIWCHLH-UHFFFAOYSA-M

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 204875   

TargetAdenosine receptor A3(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 204875BDBM204875(US9227979, 24 | EA8/MRS5817)
Affinity DataKi:  96.7nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2016
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 204875BDBM204875(US9227979, 24 | EA8/MRS5817)
Affinity DataKi:  106nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2016
Entry Details
US Patent